Ni J - Search Results

1

Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas.

Xie S, Ni J, McFaline-Figueroa JR, Wang Y, Bronson RT, Ligon KL, Wen PY, Roberts TM, Zhao JJ. Xie S, et al. Among authors: ni j. Cell Rep. 2020 Sep 29;32(13):108196. doi: 10.1016/j.celrep.2020.108196. Cell Rep. 2020. PMID: 32997991 Free PMC article.

2

A PI3K p110β-Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis.

Yuzugullu H, Baitsch L, Von T, Steiner A, Tong H, Ni J, Clayton LK, Bronson R, Roberts TM, Gritsman K, Zhao JJ. Yuzugullu H, et al. Among authors: ni j. Nat Commun. 2015 Oct 7;6:8501. doi: 10.1038/ncomms9501. Nat Commun. 2015. PMID: 26442967 Free PMC article.

3

Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss.

Cizmecioglu O, Ni J, Xie S, Zhao JJ, Roberts TM. Cizmecioglu O, et al. Among authors: ni j. Elife. 2016 Oct 4;5:e17635. doi: 10.7554/eLife.17635. Elife. 2016. PMID: 27700986 Free PMC article.

4

The role of the PIK3CA gene in the development and aging of the brain.

Xie S, Ni J, Guo H, Luu V, Wang Y, Zhao JJ, Roberts TM. Xie S, et al. Among authors: ni j. Sci Rep. 2021 Jan 11;11(1):291. doi: 10.1038/s41598-020-79416-6. Sci Rep. 2021. PMID: 33431926 Free PMC article.

5

Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent.

Ni J, Liu Q, Xie S, Carlson C, Von T, Vogel K, Riddle S, Benes C, Eck M, Roberts T, Gray N, Zhao J. Ni J, et al. Cancer Discov. 2012 May;2(5):425-33. doi: 10.1158/2159-8290.CD-12-0003. Epub 2012 Apr 12. Cancer Discov. 2012. PMID: 22588880 Free PMC article.

6

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.

Ni J, Ramkissoon SH, Xie S, Goel S, Stover DG, Guo H, Luu V, Marco E, Ramkissoon LA, Kang YJ, Hayashi M, Nguyen QD, Ligon AH, Du R, Claus EB, Alexander BM, Yuan GC, Wang ZC, Iglehart JD, Krop IE, Roberts TM, Winer EP, Lin NU, Ligon KL, Zhao JJ. Ni J, et al. Nat Med. 2016 Jul;22(7):723-6. doi: 10.1038/nm.4120. Epub 2016 Jun 6. Nat Med. 2016. PMID: 27270588 Free PMC article.

7

Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method.

Liu Z, Wang Y, Kabraji S, Xie S, Pan P, Liu Z, Ni J, Zhao JJ. Liu Z, et al. Among authors: ni j. Sci Rep. 2019 Jan 24;9(1):622. doi: 10.1038/s41598-018-36874-3. Sci Rep. 2019. PMID: 30679540 Free PMC article.

8

Tyrosine receptor kinase B is a drug target in astrocytomas.

Ni J, Xie S, Ramkissoon SH, Luu V, Sun Y, Bandopadhayay P, Beroukhim R, Roberts TM, Stiles CD, Segal RA, Ligon KL, Hahn WC, Zhao JJ. Ni J, et al. Neuro Oncol. 2017 Jan;19(1):22-30. doi: 10.1093/neuonc/now139. Epub 2016 Jul 10. Neuro Oncol. 2017. PMID: 27402815 Free PMC article.

9

Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?

Kabraji S, Ni J, Lin NU, Xie S, Winer EP, Zhao JJ. Kabraji S, et al. Among authors: ni j. Clin Cancer Res. 2018 Apr 15;24(8):1795-1804. doi: 10.1158/1078-0432.CCR-17-3351. Epub 2018 Feb 6. Clin Cancer Res. 2018. PMID: 29437794 Free PMC article.

10

p16^INK4A-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases.

Ni J, Kabraji S, Xie S, Wang Y, Pan P, He X, Liu Z, Leone JP, Long HW, Brown MA, Winer EP, Dillon DAR, Lin NU, Zhao JJ. Ni J, et al. Nat Commun. 2022 Mar 18;13(1):1473. doi: 10.1038/s41467-022-29081-2. Nat Commun. 2022. PMID: 35304445 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,053 results

Search Page

Filters